{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T08:06:26Z","timestamp":1783238786195,"version":"3.54.6"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.mayocp.2023.08.012","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T04:59:06Z","timestamp":1701406746000},"page":"1797-1808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Benefit of Anticoagulation Early After Surgical Aortic Valve Replacement Using Bioprosthetic Valves"],"prefix":"10.1016","volume":"98","author":[{"given":"Ying","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartzell V.","family":"Schaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavya S.","family":"Swarna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey R.","family":"Sangaralingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick A.","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Dearani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Crestanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin L.","family":"Greason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mayocp.2023.08.012_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtcvs.2017.08.121","article-title":"Bioprosthetic aortic valve replacement: revisiting prosthesis choice in patients younger than 50 years old","volume":"155","author":"Schnittman","year":"2018","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.mayocp.2023.08.012_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2018.4679","article-title":"Association between antithrombotic medication use after bioprosthetic aortic valve replacement and outcomes in the Veterans Health Administration system","volume":"154","author":"Bravata","year":"2019","journal-title":"JAMA Surg"},{"issue":"4","key":"10.1016\/j.mayocp.2023.08.012_bib3","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"77","author":"Otto","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.mayocp.2023.08.012_bib4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.mayocp.2023.08.012_bib5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.athoracsur.2022.05.056","article-title":"Anticoagulation after bioprosthetic aortic valve replacement: are we following the guidelines?","volume":"115","author":"Huang","year":"2023","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.mayocp.2023.08.012_bib6","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0735-1097(94)00563-6","article-title":"High risk of thromboemboli early after bioprosthetic cardiac valve replacement","volume":"25","author":"Heras","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.mayocp.2023.08.012_bib7","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jtcvs.2004.11.028","article-title":"Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?","volume":"129","author":"Sundt","year":"2005","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"11","key":"10.1016\/j.mayocp.2023.08.012_bib8","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jacc.2012.05.029","article-title":"Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database","volume":"60","author":"Brennan","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.mayocp.2023.08.012_bib9","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.jacc.2020.08.083","article-title":"Variations in anticoagulation practice following bioprosthetic aortic and mitral valve replacement and repair","volume":"76","author":"Mori","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.mayocp.2023.08.012_bib10","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1001\/jama.2012.54506","article-title":"Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding","volume":"308","author":"Merie","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mayocp.2023.08.012_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/heartjnl-2016-309630","article-title":"Anticoagulation versus antiplatelet or no therapy in patients undergoing bioprosthetic valve implantation: a systematic review and meta-analysis","volume":"103","author":"Masri","year":"2017","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.mayocp.2023.08.012_bib12","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1377\/hlthaff.2014.0038","article-title":"Optum Labs: building a novel node in the learning health care system","volume":"33","author":"Wallace","year":"2014","journal-title":"Health Aff (Millwood)"},{"issue":"11","key":"10.1016\/j.mayocp.2023.08.012_bib13","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"issue":"4","key":"10.1016\/j.mayocp.2023.08.012_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000355981","article-title":"Using the CHADS2 and CHA2DS2-VASc scores for stroke risk prediction as well as the identification of stroke outcomes and cardiac complications in patients with and without atrial fibrillation","volume":"36","author":"Lip","year":"2013","journal-title":"Cerebrovasc Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2023.08.012_bib15","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A\u00a0novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.mayocp.2023.08.012_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCOUTCOMES.113.000371","article-title":"Validity of International Classification of Disease codes to identify ischemic stroke and intracranial hemorrhage among individuals with associated diagnosis of atrial fibrillation","volume":"8","author":"Thigpen","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"20","key":"10.1016\/j.mayocp.2023.08.012_bib17","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1001\/jama.2018.6024","article-title":"Association of surgical left atrial appendage occlusion with subsequent stroke and mortality among patients undergoing cardiac surgery","volume":"319","author":"Yao","year":"2018","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.mayocp.2023.08.012_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.006515","article-title":"Comparative effectiveness and safety of oral anticoagulants across kidney function in patients with atrial fibrillation","volume":"13","author":"Yao","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"27","key":"10.1016\/j.mayocp.2023.08.012_bib19","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1002\/sim.7501","article-title":"Practical recommendations for reporting Fine-Gray model analyses for competing risk data","volume":"36","author":"Austin","year":"2017","journal-title":"Stat Med"},{"issue":"19","key":"10.1016\/j.mayocp.2023.08.012_bib20","first-page":"II95","article-title":"Anticoagulation is unnecessary after biological aortic valve replacement","volume":"98","author":"Moinuddeen","year":"1998","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.mayocp.2023.08.012_bib21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.athoracsur.2006.07.041","article-title":"Early antithrombotic therapy for aortic valve bioprostheses: is there an indication for routine use?","volume":"83","author":"Jamieson","year":"2007","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10.1016\/j.mayocp.2023.08.012_bib22","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jtcvs.2009.10.064","article-title":"Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?","volume":"139","author":"ElBardissi","year":"2010","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"9","key":"10.1016\/j.mayocp.2023.08.012_bib23","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.jacc.2019.06.058","article-title":"Anticoagulation after surgical or transcatheter bioprosthetic aortic valve replacement","volume":"74","author":"Chakravarty","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.mayocp.2023.08.012_bib24","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.jtcvs.2019.04.096","article-title":"Influence of warfarin on cardiac and cerebrovascular events following bioprosthetic aortic valve replacement: a nationwide cohort study","volume":"159","author":"Chang","year":"2020","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.mayocp.2023.08.012_bib25","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1161\/CIRCULATIONAHA.106.176857","volume":"114","author":"Bonow","year":"2006","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.mayocp.2023.08.012_bib26","first-page":"e523","volume":"118","author":"Bonow","year":"2008","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.mayocp.2023.08.012_bib27","first-page":"e521","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Nishimura","year":"2014","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.mayocp.2023.08.012_bib28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"70","author":"Nishimura","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.mayocp.2023.08.012_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.698784","article-title":"Anticoagulation therapy after biologic aortic valve replacement","volume":"8","author":"Myllykangas","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"10.1016\/j.mayocp.2023.08.012_bib30","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/heartjnl-2019-315453","article-title":"Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacement","volume":"106","author":"Christersson","year":"2020","journal-title":"Heart"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619623004044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619623004044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:41:00Z","timestamp":1758418860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619623004044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0025619623004044"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2023.08.012","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benefit of Anticoagulation Early After Surgical Aortic Valve Replacement Using Bioprosthetic Valves","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2023.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}